BNB Plus Corp. has secured initial commitments for $4.1 million through a convertible preferred stock financing round, with the company expecting total proceeds to rise to approximately $5 million. The funding is intended to strengthen its digital asset reserves while supporting a broader strategic review of both its crypto-focused operations and legacy biotechnology business.
The Nasdaq-listed firm, which trades under the ticker BNBX, said the financing was led by investors tied to Silvermine Capital Advisors, LLC, including the Comstock Multichain Fund, alongside crypto-native institutional investors such as Off the Chain LP. The company also announced a strategic advisory partnership with GlobalStake Infrastructure, LLC, which will oversee the review of BNB Plus’s assets, capital structure, and long-term business direction.
BNB Plus stated that, following the financing, it expects to hold more than $16.4 million in combined cash and digital assets based on valuations as of May 23, 2026. For a company with a relatively small balance sheet, the capital raise is significant and could materially reshape its treasury strategy over the next year.
Financing Structure Gives Investors Priority Terms
The transaction consists of two classes of convertible preferred stock: Series B-1 and Series B-2. Both instruments are senior to common shares and can convert into common stock on a one-for-one basis. The Series B-1 preferred shares are priced at $1.05 each, a substantial premium to BNB Plus’s recent market price, and include an 8% annual dividend along with a 1.5x liquidation preference. Investors participating in this tranche will also receive warrants allowing them to purchase additional common shares at $0.76 over a three-year period.
Meanwhile, the Series B-2 preferred shares are priced at $0.38 and carry a lower 6% dividend and a 1.0x liquidation preference. These shares are primarily being offered to existing investors willing to exchange common stock or previously issued warrants. The company added that it may defer cash dividend payments for the first two years by rolling unpaid dividends into the principal value of the preferred shares. That provision could preserve liquidity while management evaluates new strategic initiatives.
Shift Toward Crypto and AI Infrastructure
The financing highlights BNB Plus’s continued transition away from its earlier identity as Applied DNA Sciences, a biotechnology-focused business. Although the company still operates biotech subsidiary LineaRx, BNB Plus secured $4.1 million in new funding, with management increasingly focused on digital assets, yield-generation strategies tied to the Binance ecosystem, and infrastructure linked to blockchain and AI.
According to the company, the strategic review will focus on two primary areas: expanding digital asset and AI infrastructure opportunities, and evaluating monetization options for LineaRx. Those options could include licensing deals, partnerships, asset sales, or other transactions aimed at unlocking shareholder value.
The involvement of GlobalStake is notable because the company operates validator infrastructure and staking systems across multiple blockchain networks. BNB Plus also referenced opportunities involving institutional yield generation and “agentic AI” payment systems, though it did not provide detailed operational plans or projected capital expenditures related to AI infrastructure.
Market Context Reflects Growing Treasury Trend
BNB Plus joins a growing group of smaller publicly traded firms attempting to build investor interest around crypto treasury strategies. Over the past year, several listed companies have raised capital to accumulate digital assets or reposition themselves around blockchain infrastructure themes.
The strategy mirrors a broader market trend in which companies seek exposure to both crypto and artificial intelligence narratives simultaneously, including emerging areas like agentic AI infrastructure. While larger firms have focused on Bitcoin treasury accumulation, smaller players like BNB Plus are increasingly emphasizing staking yields, blockchain infrastructure, and AI-related services as potential growth areas.
However, the approach also introduces concentrated risk. Crypto treasury companies remain highly dependent on digital asset prices, investor sentiment, and access to additional financing. In BNB Plus’s case, the company is pairing that volatility with ambitions tied to AI infrastructure, another sector where valuations and competitive pressures remain elevated.
Whether the financing ultimately strengthens the company’s long-term position may depend less on fundraising itself and more on how effectively management converts those funds into sustainable revenue-generating operations.
FAQs
1. What is BNB Plus raising funds for?
BNB Plus said the financing proceeds will support its digital asset treasury, provide working capital, and fund a strategic review of its crypto and biotech businesses.
2. Who are the investors involved?
The financing includes participation from Comstock Multichain Fund, managed by Silvermine Capital Advisors, along with other digital asset-focused institutional investors such as Off the Chain LP.
3. What role does AI infrastructure play in the company’s plans?
BNB Plus said its strategic review will explore opportunities involving AI infrastructure and digital asset systems, including blockchain-related yield generation, AI-linked payment mechanisms, and AI-driven financial infrastructure.
